Portfolio company
Omeza
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops marine-derived wound care products using fish peptides for healthcare providers treating patients with chronic or hard-to-heal skin ulcers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Onya
This biotechnology company develops advanced therapies and medical dressings to treat chronic and acute wounds for patients with delayed healing.
Piomic Medical
This company develops a portable medical device using concurrent optical and magnetic stimulation to treat chronic leg and foot ulcers for healthcare providers.
DEBx Medical
This company develops chemical debridement agents for healthcare professionals to treat chronic wounds by removing infection and biofilm.
Vaporox
This company develops medical devices for healing chronic wounds by delivering concentrated oxygen and water vapor to healthcare facilities and clinics.
Reapplix
This company develops blood-derived patches used by healthcare providers to treat patients with hard-to-heal diabetic foot ulcers.
Piomic
The company develops a portable device using optical and magnetic stimulation to treat chronic wounds for patients in clinical and homecare settings.
Plasmacure
This company develops cold plasma medical devices for healthcare professionals to treat chronic wounds such as diabetic foot ulcers and pressure sores.
MyWoundDoctor
This company provides a telehealth platform for virtual wound care management and clinical advice to correctional facilities, health plans and individual patients.
